Calcified / Mineralized Papillary Muscle on Echocardiography

What It Looks Like on Echo

1. Dense/dystrophic calcification - homogeneous bright echogenicity, often with posterior acoustic shadowing. Seen in ischemic scar tissue, post-radiation, or metabolic disorders.
2. Caseous calcification of the papillary muscle (CCPM) - a rarer variant with a characteristic appearance: a large, echo-dense mass with central echolucencies (resembling liquefaction / "toothpaste-like" content on MRI), no acoustic shadowing, and no flow in the central zone on color Doppler. This morphology is well-described for the mitral annulus but also occurs in papillary muscles, as described in recent case literature. [PMID: 37977841]

Causes / Etiology

Echo Views and Protocol

• Parasternal short-axis (PSAX) at papillary muscle level - best single view; both anterolateral and posteromedial PMs seen
• Apical 4-chamber and 2-chamber - assess extent, involvement of chordae or LV wall
• Color Doppler - evaluate for associated mitral regurgitation (MR); no flow within the calcific mass differentiates it from a vascular mass
• TEE - superior resolution for posterior structures; use when TTE quality is limited or the mass morphology is unclear
• 3D echo - useful for defining extent and relationship to mitral subvalvular apparatus

Key Associations and Clinical Consequences

• Mitral regurgitation - calcified PM with restricted or fibrotic chordae causes tethering of leaflets, especially posterior leaflet - a cause of functional/ischemic MR
• Papillary muscle dysfunction - distinct from rupture; ischemic fibrosis impairs coordinated PM contraction, contributing to dynamic MR
• Ventricular arrhythmias - structural abnormalities of PMs (including fibrosis and calcification) are recognized substrates for papillary muscle ventricular tachycardia. [PMID: 39708031]
• Cardioembolic stroke - caseous calcification of the papillary muscle has been reported as a cause of embolic stroke and retinal artery occlusion; calcium debris can embolize [PMID: 37977841]
• LV outflow obstruction - rarely, a very large calcific mass can cause dynamic obstruction

Differentiation from Other Echo Masses

Multimodality Imaging

• Cardiac CT - confirms calcification definitively; quantifies density; distinguishes calcification from soft tissue masses (Hounsfield units > 130 HU = calcification)
• Cardiac MRI - gold standard for tissue characterization; caseous calcification shows characteristic "toothpaste" appearance; late gadolinium enhancement at PM indicates fibrosis/infarction
• Plain chest X-ray - dense calcification may appear as an intracardiac density if large enough

Management

• Incidental, asymptomatic calcification - conservative; no specific intervention needed; monitor with serial echo
• Associated MR - manage per standard mitral regurgitation guidelines (medical therapy for heart failure, surgical repair/replacement for severe symptomatic MR)
• Embolic risk (CCPM) - anticoagulation or antiplatelet therapy is debated; surgical excision is considered for recurrent emboli, though risks of operating near the subvalvular apparatus are significant
• Genetic/metabolic work-up - if calcification is extensive or unusual in distribution (young patient, multiorgan involvement), evaluate for PXE, renal osteodystrophy, or other systemic calcification syndromes
• Arrhythmia - if PM calcification is identified as a VT substrate, catheter ablation may be required, though the calcified scar can make ablation more challenging

Key Points

• Mineralized PM on echo is most often incidental and ischemic in origin
• The posteromedial PM is more frequently affected due to its single-vessel blood supply
• Caseous calcification of the papillary muscle is a distinct rare variant - recognize the "toothpaste mass" appearance (dense rim + central echolucent core, no acoustic shadowing)
• Always search for associated MR, wall motion abnormalities, and LV dysfunction
• Cardiac CT/MRI should be used when the diagnosis is uncertain or when surgical planning is needed
• Unusual or extensive calcification in a young patient should prompt genetic testing (ABCC6/PXE)

Mineralized / Echogenic Papillary Muscle in the Newborn on Echocardiography

1. Echogenic Intracardiac Focus (EIF) - The Most Common Scenario

• Found in up to 5% of normal pregnancies overall
• Up to 20% in Asian populations (higher background frequency)
• Found in 13-18% of Down syndrome pregnancies

• Small, discrete, round hyperechoic spot within the PM (usually left ventricle, less commonly right)
• Same brightness as bone - key criterion
• No posterior acoustic shadowing (distinguishes from dense adult-type calcification)
• No mass effect, no flow on color Doppler
• Most often anterolateral PM of the LV
• Can be unilateral or bilateral; right and left occurrence carry equal risk

2. EIF as a Soft Marker for Aneuploidy (Trisomy 21)

• Creasy & Resnik's Maternal-Fetal Medicine

3. Other Causes of True PM Calcification in the Newborn

a) Perinatal / Neonatal Hypoxic-Ischemic Injury

• Perinatal asphyxia causes myocardial ischemia; the posteromedial PM is most vulnerable (single coronary supply territory)
• Ischemic necrosis leads to dystrophic calcification
• Seen in the context of HIE, low Apgar scores, birth depression, meconium aspiration
• Echo will also show: wall motion abnormalities, transient myocardial ischemia (TMI), tricuspid regurgitation, pulmonary hypertension, poor LV function
• The PM calcification may appear within days to weeks after the insult

b) Infant of Diabetic Mother (IDM)

• Maternal hyperglycemia causes fetal hyperinsulinism, leading to myocardial hypertrophy (especially septal hypertrophy / HOCM picture)
• Increased metabolic demand + myocardial hypertrophy can cause relative ischemia and PM involvement
• PM echogenicity in IDM is well recognized; may be part of the hypertrophic cardiomyopathy picture

c) Congenital Heart Disease with PM Involvement

• Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) - presents in infancy/neonatal period with anterior PM ischemia and MR; PM brightness reflects infarction
• Any CHD causing severely reduced coronary perfusion in utero or postnatally

d) Maternal Connective Tissue Disease / Lupus

• Anti-Ro/La antibodies cause fetal AV block and can cause valvular / subvalvular tissue damage including calcification and degeneration of AV valves and their support structures (PMID: 7991440)

e) Metabolic / Genetic Disorders (Rare in Neonates)

• Hereditary calcification syndromes (e.g., pseudoxanthoma elasticum/ABCC6 - though onset is typically later)
• Neonatal hypercalcemia: Williams syndrome (elfin facies, supravalvular AS, hypercalcemia) - calcium deposition possible
• Idiopathic arterial calcification of infancy (IACI / GACI): rare life-threatening condition with diffuse vascular and intracardiac calcification including PM; caused by ENPP1 mutations; presents with heart failure, hypertension, and calcification in multiple cardiac structures in the first months of life

f) TORCH Infections

• Congenital CMV, toxoplasmosis, and rubella can cause intracardiac calcification as part of widespread soft tissue mineralization

4. Practical Echo Protocol in a Neonate with PM Mineralization

5. Management by Cause

Key Points for Neonatal PM Mineralization

1. Small, isolated EIF = most common = almost always benign; primary concern is as a soft marker for Trisomy 21, not a cardiac functional problem
2. True PM calcification in a neonate (dense, large, with shadowing, diffuse) is pathological - think perinatal asphyxia first, then IDM, ALCAPA, IACI, TORCH
3. Always assess for MR - even partial PM dysfunction from ischemia can cause significant mitral regurgitation and heart failure in a neonate
4. IACI/GACI is rare but life-threatening - consider it when calcification is extensive and multifocal in a neonate presenting with heart failure in the first weeks of life
5. The neonatal heart is highly vulnerable to ischemic injury because both papillary muscles in the fetus receive blood partly from the pulmonary circulation; any disruption to this supply (perinatal hypoxia, ALCAPA) preferentially affects PM tissue